Janus Henderson Group PLC Raises Holdings in Bruker Co. (NASDAQ:BRKR)

Janus Henderson Group PLC raised its stake in shares of Bruker Co. (NASDAQ:BRKR) by 3.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 869,205 shares of the medical research company’s stock after buying an additional 29,566 shares during the quarter. Janus Henderson Group PLC owned about 0.60% of Bruker worth $81,648,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of BRKR. Rise Advisors LLC purchased a new position in shares of Bruker during the 1st quarter worth $27,000. Lindbrook Capital LLC boosted its position in Bruker by 68.2% in the 4th quarter. Lindbrook Capital LLC now owns 360 shares of the medical research company’s stock valued at $26,000 after buying an additional 146 shares during the last quarter. Covestor Ltd increased its holdings in Bruker by 139.1% during the 1st quarter. Covestor Ltd now owns 361 shares of the medical research company’s stock worth $34,000 after purchasing an additional 210 shares during the last quarter. Neo Ivy Capital Management acquired a new stake in Bruker in the fourth quarter valued at $30,000. Finally, GAMMA Investing LLC bought a new position in Bruker during the 4th quarter valued at $33,000. Hedge funds and other institutional investors own 79.52% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. StockNews.com cut shares of Bruker from a “buy” rating to a “hold” rating in a research report on Tuesday, May 21st. Jefferies Financial Group assumed coverage on Bruker in a research report on Monday, June 3rd. They set a “buy” rating and a $85.00 price target on the stock. The Goldman Sachs Group decreased their price objective on shares of Bruker from $72.00 to $60.00 and set a “sell” rating for the company in a report on Tuesday, July 9th. Bank of America dropped their target price on shares of Bruker from $95.00 to $90.00 and set a “buy” rating on the stock in a report on Monday, May 20th. Finally, Citigroup decreased their price target on shares of Bruker from $95.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday, July 10th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, Bruker currently has a consensus rating of “Moderate Buy” and an average price target of $81.78.

Bruker Price Performance

Shares of NASDAQ:BRKR traded up $2.27 during trading hours on Wednesday, hitting $70.21. 259,915 shares of the company’s stock traded hands, compared to its average volume of 1,002,047. The company’s fifty day simple moving average is $65.72 and its two-hundred day simple moving average is $76.04. The company has a market cap of $10.20 billion, a price-to-earnings ratio of 24.71, a price-to-earnings-growth ratio of 2.34 and a beta of 1.20. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.91 and a current ratio of 1.81. Bruker Co. has a 52 week low of $53.79 and a 52 week high of $94.86.

Bruker (NASDAQ:BRKR) last released its earnings results on Thursday, May 2nd. The medical research company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.46 by $0.07. The business had revenue of $721.70 million during the quarter, compared to analyst estimates of $729.88 million. Bruker had a net margin of 13.38% and a return on equity of 27.31%. The business’s quarterly revenue was up 5.3% on a year-over-year basis. During the same period in the prior year, the business earned $0.64 earnings per share. As a group, equities analysts anticipate that Bruker Co. will post 2.66 EPS for the current fiscal year.

Bruker Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 17th. Investors of record on Monday, June 3rd were issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.28%. The ex-dividend date of this dividend was Monday, June 3rd. Bruker’s payout ratio is 7.27%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.